Evidence map›Paper›PMID 10507760›Full record

ArticleBritish journal of cancer1999

Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion.

M P Pereda, U Hopfner, U Pagotto, U Renner, E Uhl, E Arzt, C Missale, G K Stalla

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Retinoic acid prevents experimental Cushing syndrome.The Journal of clinical investigation · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

M P PeredaMax-Planck Institute of Psychiatry, Department of Endocrinology, Munich, Germany.
U Hopfner
U Pagotto
U Renner
E Uhl
E Arzt
C Missale
G K Stalla
Max Planck Institute of Psychiatry · DEMax Planck Society · DEUkrainian Free University · DEUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are tumours derived from the arachnoid and pia mater. During embryogenesis, these membranes develop from the migrating craniofacial neural crest. We have previously demonstrated that meningiomas have characteristic features of embryonic meninges. Craniofacial neural crest derivatives are affected during normal development and migration by retinoic acid. We speculated, therefore, that meningioma cell migration and invasion would be affected in a similar way. In this study we investigated the mechanisms of invasion and migration in meningiomas and the effects of retinoic acid (RA). We found that low doses of RA inhibit in vitro invasion in meningioma cells, without affecting cell proliferation or viability. The matrix metalloproteinases MMP-2 (72 kDa gelatinase) and MMP-9 (92 kDa gelatinase), which play a key role in invasion in other tumours, are not affected by RA. RA inhibits cell migration on collagen I and fibronectin. A possible mechanism for these effects is provided by the fact that RA strongly stimulates adhesion of meningioma cells to extracellular matrix substrates. As in vitro invasion, migration and decreased adhesion to the extracellular matrix correlate with the clinical manifestation of tumour invasion, we conclude that RA induces a non-invasive phenotype in meningioma cells.

Indexed as

Cell AdhesionCell DivisionCollagenasesCulture Media, ConditionedExtracellular MatrixGelatinasesHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Meningeal NeoplasmsMeningiomaMetalloendopeptidasesNeoplasm InvasivenessNeoplasm ProteinsTretinoinTumor Cells, CulturedCollagenasesCulture Media, ConditionedGelatinasesMatrix Metalloproteinase 2Matrix Metalloproteinase 9MetalloendopeptidasesNeoplasm ProteinsTretinoin

Identifiers

PMID10507760
PMCPMC2362913
OpenAlexW2038265092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.